Home
Scholarly Works
Azacitidine and venetoclax for the treatment of...
Journal article

Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series

Authors

Garcia-Horton A; Maze D; McNamara CJ; Sibai H; Gupta V; Murphy T

Journal

Leukemia & Lymphoma, Vol. 62, No. 6, pp. 1525–1527

Publisher

Taylor & Francis

Publication Date

May 12, 2021

DOI

10.1080/10428194.2020.1869961

ISSN

1042-8194

Contact the Experts team